SCHEMBL6846632

SCHEMBL6846632

CC(=O)c1ccc(OCCCC2CCCN2NC(=O)c2cccnc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH2 P25021 3/20 0.60
HRH1 P35367 3/20 0.60
HRH3 Q9Y5N1 7/20 0.50
TSHR P16473 2/20 0.43
LMNA P02545 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
KDM4E B2RXH2 1/20 0.43
MAPK1 P28482 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
CHRNA1 P02708 1/20 0.42
CHRNB1 P11230 1/20 0.42
CHRNB2 P17787 1/20 0.42
CHRNB4 P30926 1/20 0.42
CHRNA3 P32297 1/20 0.42
CHRNA7 P36544 1/20 0.42
CHRNA4 P43681 1/20 0.42
CHRNB3 Q05901 1/20 0.42
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6846641 0.82 HRH2 (0.61) HRH2HRH1HRH3TSHRLMNA
SCHEMBL6842224 0.82 HRH2 (0.58) HRH2HRH1HRH3KDM4EMAPT
SCHEMBL6846808 0.80 KDM4E (0.49) HRH2HRH1HRH3KDM4ESMN1; SMN2
SCHEMBL5215408 0.79 HRH2 (0.69) HRH2HRH1HRH3KDM4E
SCHEMBL5220966 0.76 P2RX7 (0.49) HRH2HRH1HRH3NFKB1
SCHEMBL6848227 0.75 KDM4E (0.46) HRH2HRH1HRH3KDM4E
SCHEMBL28715490 0.73 SMN1; SMN2 (0.51) HRH3TSHRKDM4EMAPK1NPSR1
SCHEMBL6847409 0.73 KMT2A (0.42) HRH2HRH1TSHRLMNAKDM4E
SCHEMBL5499404 0.73 TSHR (0.48) TSHRMAPK1NPSR1NPC1MAPT
SCHEMBL6847424 0.72 HRH2 (0.59) HRH2HRH1HRH3KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1467727-A1 1,3-DISUBSTITUTED AND 1,3,3,-TRISUBSTITUTED PYRROLIDINES AS HISTAMINE-3 RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS Abbott Laboratories (US) 2004-10-20 EP disclosed
WO-2003059341-A1 1,3-DISUBSTITUTED AND 1,3,3,-TRISUBSTITUTED PYRROLIDINES AS HISTAMINE-3 RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS ABBOTT LABORATORIES (US) 2003-07-24 WO disclosed